Aminophylline
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01223 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | migraine disorder | KG + DL |
| 2 | migraine with brainstem aura | KG + DL |
| 3 | migraine with or without aura, susceptibility to | KG + DL |
| 4 | atrophoderma vermiculata | KG + DL |
| 5 | ulerythema ophryogenesis | KG + DL |
| 6 | Prinzmetal angina | KG + DL |
| 7 | pulmonary hypertension | KG + DL |
| 8 | sciatic neuropathy | KG + DL |
| 9 | hyperthyroidism | KG + DL |
| 10 | kyphoscoliotic heart disease | KG + DL |
| 11 | peripheral arterial disease | KG + DL |
| 12 | tendinitis | KG + DL |
| 13 | fibromyalgia | KG + DL |
| 14 | resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta | KG + DL |
| 15 | peripheral vascular disease | KG + DL |
| 16 | idiopathic granulomatous myositis | KG + DL |
| 17 | myositis fibrosa | KG + DL |
| 18 | female breast carcinoma | KG + DL |
| 19 | amenorrhea (disease) | KG + DL |
| 20 | ischemic disease | KG + DL |
| 21 | rheumatoid arthritis | KG + DL |
| 22 | inclusion body myositis | KG + DL |
| 23 | non-inflammatory vasculopathy | KG + DL |
| 24 | keratosis pilaris | KG + DL |
| 25 | angiodysplasia | KG + DL |
| 26 | thrombotic disease | KG + DL |
| 27 | vascular ectasia | KG + DL |
| 28 | headache disorder | KG + DL |
| 29 | venous thromboembolism | KG + DL |
| 30 | fibrocartilaginous embolism | KG + DL |
| 31 | intermittent vascular claudication | KG + DL |
| 32 | hyperthyroxinemia | KG + DL |
| 33 | congenital renal artery stenosis | KG + DL |
| 34 | vein disease | KG + DL |
| 35 | brachydactyly-syndactyly syndrome | KG + DL |
| 36 | trigeminal autonomic cephalalgia | KG + DL |
| 37 | intracranial arteriosclerosis | KG + DL |
| 38 | Raynaud disease | KG + DL |
| 39 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 40 | leprosy | KG + DL |
| 41 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 42 | Graves disease | KG + DL |
| 43 | vascular insufficiency disorder | KG + DL |
| 44 | Monckeberg arteriosclerosis | KG + DL |
| 45 | pulmonary hypertension, primary, autosomal recessive | KG + DL |
| 46 | cytomegalovirus infection | KG + DL |
| 47 | genetic multiple congenital anomalies/dysmorphic syndrome without intellectual disability | KG + DL |
| 48 | malignant catarrh | KG + DL |
| 49 | infectious bovine rhinotracheitis | KG + DL |
| 50 | arterial calcification of infancy | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.